The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinicogenomic characterization of patients with rapid tumor progression versus sustained response to frontline systemic therapy for metastatic urothelial carcinoma (mUC).
 
Albert Jang
No Relationships to Disclose
 
Sulin Wu
No Relationships to Disclose
 
Hamsa Latha Sampath Kumar
No Relationships to Disclose
 
Ravi Kumar Kyasaram
No Relationships to Disclose
 
Chen-Han Wilfred Wu
No Relationships to Disclose
 
Laura Bukavina
No Relationships to Disclose
 
Adam C. Calaway
No Relationships to Disclose
 
Jorge A. Garcia
Honoraria - Aptitude Health; MJH Associates
Consulting or Advisory Role - Targeted Oncology
Research Funding - Genentech/Roche (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck (I); Orion (Inst); Pfizer (Inst)
Other Relationship - FDA
 
Pedro C. Barata
Honoraria - UroToday
Consulting or Advisory Role - AstraZeneca; AVEO; Bayer; BMS; Caris Life Sciences; Dendreon (Inst); Eisai; EMD Serono; Exelixis; Pfizer
Speakers' Bureau - AstraZeneca; Bayer (Inst); Caris Life Sciences (Inst); Merck; Pfizer/Astellas (Inst)
Research Funding - AVEO (Inst); Blue Earth Diagnostics (Inst); Exelixis; Merck (Inst); Pfizer (Inst)
 
Prateek Mendiratta
Stock and Other Ownership Interests - doximity
Honoraria - AstraZeneca; Cardinal Health; Seagen
Consulting or Advisory Role - Array BioPharma; Seagen
Speakers' Bureau - AstraZeneca; Merck; Seattle Genetics/Astellas
Travel, Accommodations, Expenses - Array BioPharma; AstraZeneca; Cardinal Health; Seattle Genetics/Astellas
 
Jason R Brown
Honoraria - AstraZeneca
Speakers' Bureau - EMD Serono
Research Funding - Bicycle Therapeutics (Inst); Jounce Therapeutics (Inst); Merck (Inst); Novita Pharmaceuticals (Inst); Seagen (Inst)